Mast Cell Tumor Treatment for Dogs

Palladia, a multi-kinase inhibitor, is a veterinarian-prescribed drug used to treat mast cell tumors, a prevalent cancer in dogs. This medication effectively destroys malignant cells and restricts the tumor's blood supply, resulting in tumor shrinkage or cessation of growth in certain canine patients.

Possible Side Effects

The most common side effects which may occur include diarrhea, decreased/loss of appetite, lameness, weight loss and blood in the stool.

Recommended Dosage

Use as directed by your veterinarian.

Administer an initial dosage of 3.25 mg/kg (1.48 mg/lb) of body weight, every other day. Dose reductions of 0.5 mg/kg every other day and dose interruptions (skipping your dose for up to 2 weeks) may be utilized, if needed, to manage adverse reaction at the discretion of your veterinarian. Adjust dose based on weekly veterinary checks for the first 6 weeks and approximately every 6 weeks. Palladia may be administered with or without food. Do not split tablets.

Human Warnings

NOT FOR USE IN HUMANS. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF 
CHILDREN. Children should not come in contact with PALLADIA. Keep children away from feces, urine, or vomit of treated dogs. To avoid exposure to drug, wash hands with soap and water after administering PALLADIA and wear protective gloves to prevent direct contact with feces, urine, vomit, and broken or moistened PALLADIA tablets. Place all waste materials in a plastic bag and seal before general disposal. 

Storage Instructions

Store at controlled room temperatures 68° - 77°F.

Prescription items are NON-RETURNABLE and NON-REFUNDABLE.